Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	57.23	70.42	44.79
Graham Fair Price	-6.42	80.16	85.65
PEG	202.89	-2.30	0.76
Price/Book	41.03	8.36	5.93
Price/Cash Flow	25.81	97.34	77.37
Prices/Earnings	56.02	25.27	16.20
Price/Sales	51.49	34.30	22.64
Price/FCF	25.81	97.34	77.37
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.27	0.82	0.81
Operating Margin	-7.20	0.38	0.41
ROA	-9.07	0.06	0.06
ROE	0.09	0.08	-9.61
ROIC	0.07	0.07	-0.99
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.01	0.03	-61.84
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.19	-0.16	-18.32
EPS QOQ	0.21	-0.11	-48.49
FCF QOQ	-0.15	0.09	-38.35
Revenue QOQ	0.17	-0.09	-47.82
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	36.28	33.16	-8.61
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.20	0.12	-39.50
Quick Ratio	2.55	2.55	-0.12
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	59.69	58.75	-1.57
Cash	25.49	22.87	-10.27
Capex	-2.99	-2.51	15.81
Free Cash Flow	4.57	5.05	10.33
Revenue	15.63	14.32	-8.36
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.67	2.68	0.36
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.23	0.29	28.16
Naive Interpretation	Member

06 - Financial Health · Bad

Rating